| scholarly article | Q13442814 |
| P2093 | author name string | Yang-Xin Fu | |
| Liang Zhou | |||
| Ju Qiu | |||
| Kamonwan Fish | |||
| Xiaohuan Guo | |||
| Jennifer J Heller | |||
| Zong-ming E Chen | |||
| P2860 | cites work | Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells | Q24293709 |
| TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function | Q24314628 | ||
| The aryl hydrocarbon receptor: a perspective on potential roles in the immune system | Q24338766 | ||
| Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22 | Q24648620 | ||
| IL-17 and Th17 Cells | Q27860566 | ||
| The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells | Q27860620 | ||
| Induction of intestinal Th17 cells by segmented filamentous bacteria | Q28131638 | ||
| Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans | Q28138084 | ||
| An essential function for the nuclear receptor RORgamma(t) in the generation of fetal lymphoid tissue inducer cells | Q28235728 | ||
| Transforming growth factor-beta induces development of the T(H)17 lineage | Q28237370 | ||
| Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. | Q41904687 | ||
| Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells | Q42915172 | ||
| Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals | Q43291519 | ||
| Definition of a dioxin receptor mutant that is a constitutive activator of transcription: delineation of overlapping repression and ligand binding functions within the PAS domain | Q43733986 | ||
| Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense | Q46197286 | ||
| Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells | Q46231038 | ||
| IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium | Q46485022 | ||
| Ectopic lymphoid-organ development occurs through interleukin 7-mediated enhanced survival of lymphoid-tissue-inducer cells. | Q51985115 | ||
| Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. | Q52590127 | ||
| The dual nature of TH17 cells: shifting the focus to function | Q56607716 | ||
| Lineage Relationship Analysis of RORγt+Innate Lymphoid Cells | Q57520258 | ||
| Production of Ah receptor ligands in rat fecal suspensions containing tryptophan or indole-3-carbinol | Q68271405 | ||
| Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor | Q28273769 | ||
| A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity | Q28299539 | ||
| Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity | Q28512981 | ||
| The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses | Q29614273 | ||
| Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens | Q29617432 | ||
| Phenotypic and functional features of human Th17 cells | Q29619323 | ||
| The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins | Q29620097 | ||
| Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells | Q29622847 | ||
| Innate IL-17-producing cells: the sentinels of the immune system | Q33608575 | ||
| Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. | Q33854381 | ||
| Lymphotoxin beta receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection | Q33883606 | ||
| CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. | Q33904793 | ||
| IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia | Q33984033 | ||
| D-amino acid oxidase generates agonists of the aryl hydrocarbon receptor from D-tryptophan | Q34073887 | ||
| The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. | Q34131656 | ||
| Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue–inducer cell and NK cell lineages | Q34146031 | ||
| The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. | Q34152180 | ||
| Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation | Q34412659 | ||
| RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells | Q34441341 | ||
| CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. | Q34562235 | ||
| Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes | Q34591589 | ||
| Nramp1 expression by dendritic cells modulates inflammatory responses during Salmonella Typhimurium infection. | Q34636009 | ||
| Organogenesis of lymphoid tissues | Q35096187 | ||
| Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt- lymphoid cells | Q35177247 | ||
| Role of coactivators in transcriptional activation by the aryl hydrocarbon receptor | Q35974415 | ||
| Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge. | Q36031510 | ||
| Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. | Q36229199 | ||
| IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis | Q36303708 | ||
| Regulating the regulator: factors that control levels and activity of the aryl hydrocarbon receptor | Q36400964 | ||
| Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. | Q36775236 | ||
| The search for endogenous activators of the aryl hydrocarbon receptor | Q36946755 | ||
| Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses | Q37331544 | ||
| Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity | Q37552151 | ||
| Regulation and functions of the IL-10 family of cytokines in inflammation and disease | Q37821924 | ||
| IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease | Q38423061 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 92-104 | |
| P577 | publication date | 2011-12-15 | |
| P1433 | published in | Immunity | Q6005457 |
| P1476 | title | The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells | |
| P478 | volume | 36 |
| Q97871103 | 6-Formylindolo (3, 2-b) Carbazole (FICZ)-mediated protection of gut barrier is dependent on T cells in a mouse model of alcohol combined with burn injury |
| Q61807389 | A Cell Proliferation and Inflammatory Signature Is Induced by Lawsonia intracellularis Infection in Swine |
| Q100518528 | A Double Edged Sword Role of Interleukin-22 in Wound Healing and Tissue Regeneration |
| Q113697959 | A Japanese Herbal Formula, Daikenchuto, Alleviates Experimental Colitis by Reshaping Microbial Profiles and Enhancing Group 3 Innate Lymphoid Cells |
| Q48231667 | A catch-22: Interleukin-22 and cancer |
| Q33784876 | A mouse model links asthma susceptibility to prenatal exposure to diesel exhaust |
| Q38426867 | A network of high-mobility group box transcription factors programs innate interleukin-17 production |
| Q124072989 | A response regulator controls virulence by acting as an indole receptor |
| Q26851559 | A role for Th17 cells in the regulation of tertiary lymphoid follicles |
| Q62111589 | A systematic review of gut-immune-brain mechanisms in Autism Spectrum Disorder |
| Q33818770 | A tightly regulated IL-22 response maintains immune functions and homeostasis in systemic viral infection. |
| Q36447796 | AHR Function in Lymphocytes: Emerging Concepts |
| Q38008350 | AHR and the Transcriptional Regulation of Type-17/22 ILC. |
| Q57265207 | AHR signaling in the development and function of intestinal immune cells and beyond |
| Q40067670 | Ablating the aryl hydrocarbon receptor (AhR) in CD11c+ cells perturbs intestinal epithelium development and intestinal immunity |
| Q97531803 | Activation and Suppression of Group 3 Innate Lymphoid Cells in the Gut |
| Q90021573 | Activation of Aryl Hydrocarbon Receptor Negatively Regulates Thymic Stromal Lymphopoietin Gene Expression via Protein Kinase Cδ-p300-NF-κB Pathway in Keratinocytes under Inflammatory Conditions |
| Q92265844 | Activation of DR3 signaling causes loss of ILC3s and exacerbates intestinal inflammation |
| Q33795308 | Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions |
| Q35037658 | Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. |
| Q35733882 | Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles. |
| Q96768227 | Ah receptor ligands and their impacts on gut resilience: structure-activity effects |
| Q57194204 | AhR modulates the IL-22-producing cell proliferation/recruitment in imiquimod-induced psoriasis mouse model |
| Q52874611 | AhR sensing of bacterial pigments regulates antibacterial defence. |
| Q33670663 | AhR‑E2F1‑KGFR signaling is involved in KGF‑induced intestinal epithelial cell proliferation |
| Q96347857 | Ahr-Foxp3-RORγt axis controls gut homing of CD4+ T cells by regulating GPR15 |
| Q38198280 | Allergic responses and aryl hydrocarbon receptor novel pathway of mast cell activation |
| Q39697190 | Amelioration of Clostridium difficile Infection in Mice by Dietary Supplementation With Indole-3-carbinol |
| Q99214461 | Amino Acid Metabolism in Rheumatoid Arthritis: Friend or Foe? |
| Q64963771 | An Essential Role of Innate Lymphoid Cells in the Pathophysiology of Graft-vs.-Host Disease. |
| Q38057527 | An expanding range of targets for kynurenine metabolites of tryptophan |
| Q38964535 | An in vitro model of innate lymphoid cell function and differentiation. |
| Q53689114 | Anti-TNF Therapy Induces CD4+ T-Cell Production of IL-22 and Promotes Epithelial Repairs in Patients With Crohn's Disease. |
| Q36188444 | Antibiotics, microbiota, and immune defense |
| Q47292774 | Aryl Hydrocarbon Receptor Activation Suppresses EBF1 and PAX5 and Impairs Human B Lymphopoiesis. |
| Q88490888 | Aryl Hydrocarbon Receptor Activation: From Coal to Dioxin |
| Q58574477 | Aryl Hydrocarbon Receptor Ligands Indoxyl 3-sulfate and Indole-3-carbinol Inhibit FMS-like Tyrosine Kinase 3 Ligand-induced Bone Marrow-derived plasmacytoid Dendritic Cell Differentiation |
| Q36349594 | Aryl Hydrocarbon Receptor Protects Lungs from Cockroach Allergen-Induced Inflammation by Modulating Mesenchymal Stem Cells. |
| Q93182281 | Aryl Hydrocarbon Receptor Signaling Cell Intrinsically Inhibits Intestinal Group 2 Innate Lymphoid Cell Function |
| Q91093756 | Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis |
| Q93173017 | Aryl hydrocarbon Receptor activation during in vitro and in vivo digestion of raw and cooked broccoli (brassica oleracea var. Italica) |
| Q47235556 | Aryl hydrocarbon receptor activation maintained the intestinal epithelial barrier function through Notch1 dependent signaling pathway |
| Q57096209 | Aryl hydrocarbon receptor and intestinal immunity |
| Q38268639 | Aryl hydrocarbon receptor and kynurenine: recent advances in autoimmune disease research |
| Q38015276 | Aryl hydrocarbon receptor controls regulatory CD4+ T cell function. |
| Q93129521 | Aryl hydrocarbon receptor ligands enhance lung immunity through intestinal IKKβ pathways |
| Q87625973 | Aryl hydrocarbon receptor negatively regulates NLRP3 inflammasome activity by inhibiting NLRP3 transcription |
| Q44911669 | Aryl hydrocarbon receptor plays protective roles in ConA-induced hepatic injury by both suppressing IFN-γ expression and inducing IL-22. |
| Q34969719 | Aryl hydrocarbon receptor promotes RORγt⁺ group 3 ILCs and controls intestinal immunity and inflammation |
| Q42317622 | Aryl hydrocarbon receptor signaling involves in the human intestinal ILC3/ILC1 conversion in the inflamed terminal ileum of Crohn's disease patients |
| Q36378234 | Aryl hydrocarbon receptor: Linking environment to immunity |
| Q26853011 | Aryl hydrocarbon receptor: a molecular link between postnatal lymphoid follicle formation and diet |
| Q114070775 | Babies, Bugs, and Barriers: Dietary Modulation of Intestinal Barrier Function in Early Life |
| Q47135898 | Bacillus anthracis lethal toxin negatively modulates ILC3 function through perturbation of IL-23-mediated MAPK signaling. |
| Q112760907 | Bacteroides ovatus Promotes IL-22 Production and Reduces Trinitrobenzene Sulfonic Acid-Driven Colonic Inflammation |
| Q100750810 | Baicalein Restores the Balance of Th17/Treg Cells via Aryl Hydrocarbon Receptor to Attenuate Colitis |
| Q36906841 | Balancing intestinal and systemic inflammation through cell type-specific expression of the aryl hydrocarbon receptor repressor |
| Q35106239 | Benzimidazoisoquinolines: a new class of rapidly metabolized aryl hydrocarbon receptor (AhR) ligands that induce AhR-dependent Tregs and prevent murine graft-versus-host disease |
| Q52314209 | Beyond Host Defense: Emerging Functions of the Immune System in Regulating Complex Tissue Physiology. |
| Q33759935 | Beyond NK cells: the expanding universe of innate lymphoid cells. |
| Q112288033 | Bifidobacterium species associated with breastfeeding produce aromatic lactic acids in the infant gut |
| Q41996396 | Biochemical Mechanisms of Pathogen Restriction by Intestinal Bacteria |
| Q26782801 | Breast Milk and Solid Food Shaping Intestinal Immunity |
| Q96952258 | Brg1 restrains the pro-inflammatory properties of ILC3s and modulates intestinal immunity |
| Q93092528 | Bridging intestinal immunity and gut microbiota by metabolites |
| Q34541325 | Butyrate produced by commensal bacteria potentiates phorbol esters induced AP-1 response in human intestinal epithelial cells |
| Q93366244 | CCR10+ ILC2s with ILC1-like properties exhibit a protective function in severe allergic asthma |
| Q42355640 | CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis. |
| Q95297873 | COVID-19, an opportunity to reevaluate the correlation between long-term effects of anthropogenic pollutants on viral epidemic/pandemic events and prevalence |
| Q96136649 | CRISPR screen in regulatory T cells reveals modulators of Foxp3 |
| Q33964256 | CX₃CR1⁺ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. |
| Q112283865 | Cell-intrinsic Aryl Hydrocarbon Receptor signalling is required for the resolution of injury-induced colonic stem cells |
| Q27021336 | Cellular and molecular pathways through which commensal bacteria modulate sensitization to dietary antigens |
| Q49917649 | Chemical sensing in development and function of intestinal lymphocytes. |
| Q91326315 | Chemistry and Properties of Indolocarbazoles |
| Q47596967 | Clinical importance of IL-22 cascade in IBD. |
| Q34324282 | Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis |
| Q103828499 | Coarse Cereals and Legume Grains Exert Beneficial Effects through Their Interaction with Gut Microbiota: A Review |
| Q38882799 | Colonization and effector functions of innate lymphoid cells in mucosal tissues |
| Q90638800 | Commensals Suppress Intestinal Epithelial Cell Retinoic Acid Synthesis to Regulate Interleukin-22 Activity and Prevent Microbial Dysbiosis |
| Q38223965 | Complexity of cytokine network regulation of innate lymphoid cells in protective immunity |
| Q38439301 | Control of lymphocyte homeostasis and effector function by the aryl hydrocarbon receptor |
| Q27013060 | Control of pathogens and pathobionts by the gut microbiota |
| Q30240201 | Crohn's disease |
| Q49584824 | Cross-regulatory circuit between AHR and microbiota. |
| Q35785264 | Cross-talk between type 3 innate lymphoid cells and the gut microbiota in inflammatory bowel disease |
| Q36386989 | Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage |
| Q38066512 | Cytokines as molecular targets for aryl hydrocarbon receptor ligands: implications for toxicity and xenobiotic detoxification |
| Q34055620 | DOCK8 regulates protective immunity by controlling the function and survival of RORγt+ ILCs |
| Q26861554 | Deciphering the transcriptional switches of innate lymphoid cell programming: the right factors at the right time |
| Q99244456 | Decoding IL-23 Signaling Cascade for New Therapeutic Opportunities |
| Q38004228 | Development and function of intestinal innate lymphoid cells |
| Q38200397 | Development and regulation of RORγt(+) innate lymphoid cells |
| Q26829933 | Development and survival of Th17 cells within the intestines: the influence of microbiome- and diet-derived signals |
| Q38190175 | Development of human natural killer cells and other innate lymphoid cells. |
| Q38872148 | Development of innate lymphoid cells |
| Q38252608 | Development, differentiation, and diversity of innate lymphoid cells |
| Q91329423 | Dichotomous regulation of group 3 innate lymphoid cells by nongastric Helicobacter species |
| Q35243306 | Diet and host-microbial crosstalk in postnatal intestinal immune homeostasis |
| Q92857711 | Diet-Microbe-Host Interactions That Affect Gut Mucosal Integrity and Infection Resistance |
| Q94516884 | Dietary AhR Ligands Regulate AhRR Expression in Intestinal Immune Cells and Intestinal Microbiota Composition |
| Q49834562 | Dietary Broccoli Impacts Microbial Community Structure and Attenuates Chemically Induced Colitis in Mice in an Ah receptor dependent manner. |
| Q61448104 | Dietary Habits and Intestinal Immunity: From Food Intake to CD4 T Cells |
| Q112277345 | Dietary antigens suppress the proliferation of type 2 innate lymphoid cells by restraining homeostatic IL-25 production |
| Q96431485 | Dietary fiber metabolites regulate innate lymphoid cell responses |
| Q38046108 | Dietary influences on intestinal immunity |
| Q38680406 | Differentiation of human innate lymphoid cells (ILCs). |
| Q36478247 | Distinct requirements for T-bet in gut innate lymphoid cells |
| Q38608504 | Diversification and Functional Specialization of Human NK Cell Subsets. |
| Q36693141 | Diversity, function, and transcriptional regulation of gut innate lymphocytes |
| Q35057280 | Downregulation of microRNA-107 in intestinal CD11c(+) myeloid cells in response to microbiota and proinflammatory cytokines increases IL-23p19 expression |
| Q123008685 | Embryonic ILC-poiesis across tissues |
| Q35906051 | Emerging Role of Interleukin 22 in Hepatitis B Virus Infection: a Double-edged Sword |
| Q92667329 | Endocrine aryl hydrocarbon receptor signaling is induced by moderate cutaneous exposure to ultraviolet light |
| Q62806001 | Endocrine aryl hydrocarbon receptor signaling is induced by moderate cutaneous exposure to ultraviolet light: |
| Q28267904 | Engagement of the Aryl Hydrocarbon Receptor in Mycobacterium tuberculosis-Infected Macrophages Has Pleiotropic Effects on Innate Immune Signaling |
| Q28391625 | Environmental Immunology: Lessons Learned from Exposure to a Select Panel of Immunotoxicants |
| Q100526326 | Environmental pollutants and the immune response |
| Q36834659 | Epidermal Notch1 recruits RORγ(+) group 3 innate lymphoid cells to orchestrate normal skin repair |
| Q90840655 | Epigenetic initiation of the TH17 differentiation program is promoted by Cxxc finger protein 1 |
| Q122247194 | Epithelial cell invasion by salmonella typhimurium induces modulation of genes controlled by aryl hydrocarbon receptor signaling and involved in extracellular matrix biogenesis |
| Q36080691 | Epithelial-intrinsic IKKα expression regulates group 3 innate lymphoid cell responses and antibacterial immunity. |
| Q42699909 | Evidence for New Light-Independent Pathways for Generation of the Endogenous Aryl Hydrocarbon Receptor Agonist FICZ. |
| Q38574708 | Exploring the role of interleukin-22 in neurological and autoimmune disorders |
| Q35070359 | Exposure to atmospheric particulate matter enhances Th17 polarization through the aryl hydrocarbon receptor |
| Q90237512 | Faecal Microbiota Transplantation Reduces Susceptibility to Epithelial Injury and Modulates Tryptophan Metabolism of the Microbial Community in a Piglet Model |
| Q38986519 | Feedback control of AHR signalling regulates intestinal immunity |
| Q38954058 | Food Fight: Role of Itaconate and Other Metabolites in Antimicrobial Defense |
| Q39034173 | Functional and phenotypic heterogeneity of group 3 innate lymphoid cells |
| Q39116552 | Gastrointestinal immune and microbiome changes during parenteral nutrition. |
| Q37576715 | Gata3 drives development of RORγt+ group 3 innate lymphoid cells. |
| Q35470109 | Genetic and pharmacological analysis identifies a physiological role for the AHR in epidermal differentiation |
| Q36074979 | Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence. |
| Q89449439 | Glucocorticoids Inhibit Group 3 Innate Lymphocyte IL-22 Production |
| Q87994387 | Gpr109a Limits Microbiota-Induced IL-23 Production To Constrain ILC3-Mediated Colonic Inflammation |
| Q47138366 | Group 3 Innate Lymphoid Cells: Communications Hubs of the Intestinal Immune System |
| Q28081074 | Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice |
| Q36479985 | Group 3 innate lymphoid cells continuously require the transcription factor GATA-3 after commitment |
| Q37448373 | Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. |
| Q120407978 | Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) |
| Q89103994 | Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease |
| Q57044785 | Gut Microbiota-Stimulated Innate Lymphoid Cells Support β-Defensin 14 Expression in Pancreatic Endocrine Cells, Preventing Autoimmune Diabetes |
| Q90312349 | Gut dysbiosis and multiple sclerosis |
| Q38977243 | Gut microbiota and central nervous system development |
| Q49958101 | Gut microbiota injury in allogeneic haematopoietic stem cell transplantation. |
| Q89791932 | Gut microbiota-derived metabolites as key actors in inflammatory bowel disease |
| Q40073307 | Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease. |
| Q38780964 | HIV-2 infection is associated with preserved GALT homeostasis and epithelial integrity despite ongoing mucosal viral replication |
| Q37987526 | Healing of intestinal inflammation by IL-22. |
| Q38606216 | Heterogeneity and diversity of group 3 innate lymphoid cells: new cells on the block |
| Q36351062 | Homeostatic Immunity and the Microbiota |
| Q36923759 | Homeostatic PPARα Signaling Limits Inflammatory Responses to Commensal Microbiota in the Intestine. |
| Q96025669 | Host Immunity to Malassezia in Health and Disease |
| Q36295242 | Host-microbiota interactions in inflammatory bowel disease |
| Q104516516 | How Ah Receptor Ligand Specificity Became Important in Understanding Its Physiological Function |
| Q100389255 | How Microbial Food Fermentation Supports a Tolerant Gut |
| Q98388762 | How the AHR Became Important in Intestinal Homeostasis-A Diurnal FICZ/AHR/CYP1A1 Feedback Controls Both Immunity and Immunopathology |
| Q41602991 | Human RORγt(+)CD34(+) cells are lineage-specified progenitors of group 3 RORγt(+) innate lymphoid cells. |
| Q38722528 | Human innate lymphoid cells. |
| Q38916716 | Hydroxystilbenes and methoxystilbenes activate human aryl hydrocarbon receptor and induce CYP1A genes in human hepatoma cells and human hepatocytes. |
| Q97519137 | IL-10 and IL-22 in Mucosal Immunity: Driving Protection and Pathology |
| Q51756699 | IL-17 is a protection effector against the adherent-invasive Escherichia coli in murine colitis. |
| Q54117235 | IL-17-producing ST2+ group 2 innate lymphoid cells play a pathogenic role in lung inflammation. |
| Q40069845 | IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κB. |
| Q92249406 | IL-21 Controls ILC3 Cytokine Production and Promotes a Protective Phenotype in a Mouse Model of Colitis |
| Q34148906 | IL-21 induces IL-22 production in CD4+ T cells. |
| Q28534626 | IL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasis |
| Q34364633 | IL-22 fate reporter reveals origin and control of IL-22 production in homeostasis and infection |
| Q38093227 | IL-22 in tissue-protective therapy |
| Q28253099 | IL-22, cell regeneration and autoimmunity |
| Q38081171 | IL-22, not simply a Th17 cytokine |
| Q91513360 | IL-22: There Is a Gap in Our Knowledge |
| Q93214134 | IL-23 and IL-2 activation of STAT5 is required for optimal IL-22 production in ILC3s during colitis |
| Q87357975 | IL-7: AhR We Ready for a New Cytokine to Fight Colitis? |
| Q91559991 | ILC3-derived OX40L is essential for homeostasis of intestinal Tregs in immunodeficient mice |
| Q90140561 | Identification and Functional Characterization of Murine Group 3 Innate Lymphoid Cell (ILC3) Subsets in the Intestinal Tract and Associated Lymphoid Tissues |
| Q39024763 | Identification of a probiotic bacteria-derived activator of the aryl hydrocarbon receptor that inhibits colitis |
| Q37549093 | Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 production. |
| Q64118813 | IgG and Fcγ Receptors in Intestinal Immunity and Inflammation |
| Q37123699 | Ikaros Inhibits Group 3 Innate Lymphoid Cell Development and Function by Suppressing the Aryl Hydrocarbon Receptor Pathway. |
| Q39000249 | Immune modules shared by innate lymphoid cells and T cells |
| Q89965683 | Immunoregulatory Sensory Circuits in Group 3 Innate Lymphoid Cell (ILC3) Function and Tissue Homeostasis |
| Q27022027 | Immunoregulatory molecules are master regulators of inflammation during the immune response |
| Q93199884 | Impact of maternal dietary gut microbial metabolites on an offspring's systemic immune response in mouse models |
| Q50223024 | Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism. |
| Q57096245 | Impaired Aryl Hydrocarbon Receptor Ligand Production by the Gut Microbiota Is a Key Factor in Metabolic Syndrome |
| Q92979252 | Imprinting of the immune system by the microbiota early in life |
| Q40430505 | Indigo Naturalis ameliorates murine dextran sodium sulfate-induced colitis via aryl hydrocarbon receptor activation |
| Q36077694 | Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation |
| Q53077914 | Indole-3-Carbinol Promotes Goblet-Cell Differentiation Regulating Wnt and Notch Signaling Pathways AhR-Dependently. |
| Q112645365 | Indole-3-Carbinol-Dependent Aryl Hydrocarbon Receptor Signaling Attenuates the Inflammatory Response in Experimental Necrotizing Enterocolitis |
| Q91782610 | Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease |
| Q98576001 | Indoles from the commensal microbiota act via the AHR and IL-10 to tune the cellular composition of the colonic epithelium during aging |
| Q92378720 | Indoles: metabolites produced by intestinal bacteria capable of controlling liver disease manifestation |
| Q38577707 | Induction of Immune Tolerance to Dietary Antigens |
| Q37574096 | Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection |
| Q114872308 | Inflammatory Bowel Disease and COVID-19: How Microbiomics and Metabolomics Depict Two Sides of the Same Coin |
| Q38539813 | Influence of nutrient-derived metabolites on lymphocyte immunity |
| Q93264864 | Innate Lymphocyte Mechanisms in Skin Diseases |
| Q89167815 | Innate Lymphoid Cell Development: A T Cell Perspective |
| Q50228830 | Innate Lymphoid Cell Immunometabolism. |
| Q125465707 | Innate Lymphoid Cell Plasticity in Mucosal Infections |
| Q90429472 | Innate Lymphoid Cell-Epithelial Cell Modules Sustain Intestinal Homeostasis |
| Q35611711 | Innate Lymphoid Cells Control Early Colonization Resistance against Intestinal Pathogens through ID2-Dependent Regulation of the Microbiota. |
| Q42683314 | Innate Lymphoid Cells in Intestinal Inflammation |
| Q57265250 | Innate Lymphoid Cells in Mucosal Homeostasis, Infections, Autoimmune Disorders, and Tumors |
| Q64230647 | Innate Lymphoid Cells: A Link between the Nervous System and Microbiota in Intestinal Networks |
| Q98951227 | Innate Lymphoid Cells: Important Regulators of Host-Bacteria Interaction for Border Defense |
| Q92139518 | Innate Lymphoid Cells: Their Contributions to Gastrointestinal Tissue Homeostasis and HIV/SIV Disease Pathology |
| Q96584625 | Innate lymphoid cell and adaptive immune cell cross-talk: A talk meant not to forget |
| Q38872152 | Innate lymphoid cell function in the context of adaptive immunity |
| Q36390314 | Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease |
| Q91725321 | Innate lymphoid cell type 3-derived interleukin-22 boosts lipocalin-2 production in intestinal epithelial cells via synergy between STAT3 and NF-κB |
| Q87948787 | Innate lymphoid cells 3 induce psoriasis in xenotransplanted healthy human skin |
| Q93034793 | Innate lymphoid cells and cancer at border surfaces with the environment |
| Q39245925 | Innate lymphoid cells and their stromal microenvironments |
| Q38872144 | Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. |
| Q38150153 | Innate lymphoid cells in homeostasis, infection, chronic inflammation and tumors of the gastrointestinal tract |
| Q38086154 | Innate lymphoid cells in immunity and disease |
| Q38605374 | Innate lymphoid cells in intestinal immunity and inflammation |
| Q57181212 | Innate lymphoid cells in lung infection and immunity |
| Q38165175 | Innate lymphoid cells in the defense against infections |
| Q36908615 | Innate lymphoid cells in the initiation, regulation and resolution of inflammation |
| Q57181219 | Innate lymphoid cells, mediators of tissue homeostasis, adaptation and disease tolerance |
| Q27026229 | Innate lymphoid cells, possible interaction with microbiota |
| Q38890998 | Innate lymphoid cells, precursors and plasticity |
| Q38071916 | Innate lymphoid cells--how did we miss them? |
| Q88990558 | Innate lymphoid cells-key immune integrators of overall body homeostasis |
| Q35638915 | Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology |
| Q36645149 | Innate lymphoid cells: balancing immunity, inflammation, and tissue repair in the intestine. |
| Q38077406 | Innate lymphoid cells: from border protection to the initiation of inflammatory diseases |
| Q38162631 | Innate lymphoid cells: new paradigm in immunology of inflammation |
| Q38647938 | Integrative whole-genome sequence analysis reveals roles of regulatory mutations in BCL6 and BCL2 in follicular lymphoma |
| Q112750975 | Interactions between NCR+ILC3s and the Microbiome in the Airways Shape Asthma Severity |
| Q47552015 | Interactions between the microbiota and innate and innate-like lymphocytes. |
| Q90814665 | Interleukin-10 Family Cytokines Immunobiology and Structure |
| Q26770224 | Interleukin-22 Signaling in the Regulation of Intestinal Health and Disease |
| Q94513050 | Interleukin-22 and intestinal homeostasis: Protective or destructive? |
| Q35530956 | Interleukin-22: immunobiology and pathology |
| Q48151041 | Interplay of innate lymphoid cells and the microbiota. |
| Q35256610 | Interplay of nutrients and microbial metabolites in intestinal immune homeostasis: distinct and common mechanisms of immune regulation in the small bowel and colon |
| Q47143523 | Interrelated Roles for the Aryl Hydrocarbon Receptor and Hypoxia Inducible Factor-1α in the Immune Response to Infection. |
| Q61814283 | Intestinal Microbiota Influence Immune Tolerance Post Allogeneic Hematopoietic Cell Transplantation and Intestinal GVHD |
| Q36451342 | Intestinal commensal microbes as immune modulators |
| Q26765223 | Intestinal inflammation and the diet: Is food friend or foe? |
| Q98937232 | Intestinal microbial metabolites in human metabolism and type 2 diabetes |
| Q99233887 | Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity |
| Q98388036 | Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity |
| Q36790083 | Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells |
| Q57169911 | Investigational drugs in phase I and phase II clinical trials targeting interleukin 23 (IL23) for the treatment of Crohn's disease |
| Q44529319 | Keeping the peace: aryl hydrocarbon receptor signaling modulates the mucosal microbiota |
| Q38805575 | Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases |
| Q89551915 | Living with Yourself: Innate Lymphoid Cell Immunometabolism |
| Q40287938 | Long noncoding RNA lncKdm2b is required for ILC3 maintenance by initiation of Zfp292 expression. |
| Q38026289 | Lymphotoxin-beta receptor expression and its related signaling pathways govern dendritic cell homeostasis and function |
| Q26774652 | Macrophage and Innate Lymphoid Cell Interplay in the Genesis of Fibrosis |
| Q26796071 | Maintenance of Immune Homeostasis through ILC/T Cell Interactions |
| Q89744372 | Manipulation of microbiota with probiotics as an alternative for treatment of hepatic encephalopathy |
| Q37064773 | Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity. |
| Q26766654 | Mechanisms of interleukin-22's beneficial effects in acute pancreatitis |
| Q90050659 | Metabolic Control of Innate Lymphoid Cell Migration |
| Q102066528 | Metabolic Regulation of Group 3 Innate Lymphoid Cells and Their Role in Inflammatory Bowel Disease |
| Q49630984 | Metabolic Regulation of Innate Lymphoid Cell-Mediated Tissue Protection-Linking the Nutritional State to Barrier Immunity. |
| Q64982071 | Metabolite-Sensing G Protein-Coupled Receptors Connect the Diet-Microbiota-Metabolites Axis to Inflammatory Bowel Disease. |
| Q90808895 | Metabolite-Sensing Receptor Ffar2 Regulates Colonic Group 3 Innate Lymphoid Cells and Gut Immunity |
| Q37151353 | Metabolites: messengers between the microbiota and the immune system |
| Q50129679 | MicroRNA in gastrointestinal cell signalling. |
| Q36879515 | MicroRNA-375 regulation of thymic stromal lymphopoietin by diesel exhaust particles and ambient particulate matter in human bronchial epithelial cells |
| Q46257092 | Microbial Insights into Asthmatic Immunopathology. A Forward-Looking Synthesis and Commentary. |
| Q90946979 | Microbial Metabolites Determine Host Health and the Status of Some Diseases |
| Q100382722 | Microbial Metabolites, Postbiotics and Intestinal Epithelial Function |
| Q34288647 | Microbial-immune cross-talk and regulation of the immune system |
| Q93247005 | Microbiome modulates intestinal homeostasis against inflammatory diseases |
| Q39018814 | Microbiome, metabolites and host immunity. |
| Q96292272 | Microbiome-intestinal crosstalk during acute graft-versus-host disease (GVHD) |
| Q93264848 | Microbiota Metabolites in Health and Disease |
| Q95318912 | Microbiota and cancer: host cellular mechanisms activated by gut microbial metabolites |
| Q91512757 | Microbiota and metabolites in rheumatic diseases |
| Q35277854 | Microbiota control of a tryptophan-AhR pathway in disease tolerance to fungi |
| Q91891671 | Microbiota-induced tissue signals regulate ILC3-mediated antigen presentation |
| Q36554706 | Migration and Tissue Tropism of Innate Lymphoid Cells |
| Q33719835 | Modeling the Effect of the Aryl Hydrocarbon Receptor on Transplant Immunity |
| Q102326035 | Modulation of Crustacean Innate Immune Response by Amino Acids and Their Metabolites: Inferences From Other Species |
| Q35235355 | Modulation of immune development and function by intestinal microbiota. |
| Q93055870 | Modulation of lymphocyte-mediated tissue repair by rational design of heterocyclic aryl hydrocarbon receptor agonists |
| Q49710668 | Molecular characteristics of rhesus macaque interleukin-22: cloning, in vitro expression and biological activities. |
| Q38006106 | Multifaceted roles of interleukin-7 signaling for the development and function of innate lymphoid cells |
| Q102332563 | Mutual Interplay of Host Immune System and Gut Microbiota in the Immunopathology of Atherosclerosis |
| Q41175119 | NFIL3 orchestrates the emergence of common helper innate lymphoid cell precursors |
| Q91704520 | NIK signaling axis regulates dendritic cell function in intestinal immunity and homeostasis |
| Q90699508 | Neuroimmunophysiology of the gut: advances and emerging concepts focusing on the epithelium |
| Q38075724 | New friendships and old feuds: relationships between innate lymphoid cells and microbial communities |
| Q35155780 | New insights into gastrointestinal anthrax infection. |
| Q27024977 | New insights into the aryl hydrocarbon receptor as a modulator of host responses to infection |
| Q34089159 | Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens. |
| Q92082162 | Nutritional Modulation of Immune and Central Nervous System Homeostasis: The Role of Diet in Development of Neuroinflammation and Neurological Disease |
| Q99233588 | Nutritional Modulation of the Microbiome and Immune Response |
| Q94449914 | Oncobiosis and Microbial Metabolite Signaling in Pancreatic Adenocarcinoma |
| Q112706001 | Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite |
| Q54218424 | Orchestration of intestinal homeostasis and tolerance by group 3 innate lymphoid cells. |
| Q41918455 | Our gut microbiota: a long walk to homeostasis |
| Q47897160 | Pathological and therapeutic roles of innate lymphoid cells in diverse diseases |
| Q33899365 | Perfluorooctane sulfonate affects intestinal immunity against bacterial infection |
| Q64102318 | Physiological Regulation of Innate Lymphoid Cells |
| Q100381937 | Physiological function and regulatory signal of intestinal type 3 innate lymphoid cell(s) |
| Q89844154 | Phytohormones: Multifunctional nutraceuticals against metabolic syndrome and comorbid diseases |
| Q93168450 | Polyphenols and Tryptophan Metabolites Activate the Aryl Hydrocarbon Receptor in an in vitro Model of Colonic Fermentation |
| Q97412790 | Postbiotic-Enabled Targeting of the Host-Microbiota-Pathogen Interface: Hints of Antibiotic Decline? |
| Q35438377 | Prediction and quantification of bioactive microbiota metabolites in the mouse gut. |
| Q47189424 | Probiotics or Pro-healers the Role of Beneficial Bacteria in Tissue Repair |
| Q34033579 | Reciprocal interactions of the intestinal microbiota and immune system. |
| Q38205440 | Recognition strategies of group 3 innate lymphoid cells |
| Q34439411 | Regional specialization within the intestinal immune system |
| Q49544001 | Regulation of Innate Lymphoid Cells by Aryl Hydrocarbon Receptor. |
| Q93096532 | Regulation of signaling mediated by nucleic acid sensors for innate interferon-mediated responses during viral infection |
| Q49990707 | Regulation of the Immune Response by the Aryl Hydrocarbon Receptor. |
| Q37716899 | Regulation of the immune system by the resident intestinal bacteria. |
| Q35134829 | Relationship between gut microbiota and development of T cell associated disease |
| Q34289345 | Restriction of IL-22-producing T cell responses and differential regulation of regulatory T cell compartments by zinc finger transcription factor Ikaros |
| Q41970839 | Retinoic acid expression associates with enhanced IL-22 production by γδ T cells and innate lymphoid cells and attenuation of intestinal inflammation. |
| Q89937117 | Retinoic acid induced cytokines are selectively modulated by liver X receptor activation in zebrafish |
| Q35278095 | Richness and diversity of mammalian fungal communities shape innate and adaptive immunity in health and disease. |
| Q38927415 | Role of AhR in positive regulation of cell proliferation and survival |
| Q89169843 | Role of nutrition, infection, and the microbiota in the efficacy of oral vaccines |
| Q38016151 | Role of the Aryl Hydrocarbon Receptor in Controlling Maintenance and Functional Programs of RORγt(+) Innate Lymphoid Cells and Intraepithelial Lymphocytes |
| Q37292408 | Role of the aryl hydrocarbon receptor (AhR) in lung inflammation |
| Q34036490 | Role of the gut microbiota in immunity and inflammatory disease |
| Q30235535 | Roles of the intestinal microbiota in pathogen protection. |
| Q91556183 | Runx1 and RORγt Cooperate to Upregulate IL-22 Expression in Th Cells through Its Distal Enhancer |
| Q58746167 | Runx3 Mediates Resistance to Intracellular Bacterial Infection by Promoting IL12 Signaling in Group 1 ILC and NCR+ILC3 |
| Q36199803 | Runx3 specifies lineage commitment of innate lymphoid cells |
| Q39135086 | STAT3 activation in Th17 and Th22 cells controls IL-22-mediated epithelial host defense during infectious colitis |
| Q28483604 | SU5416, a VEGF receptor inhibitor and ligand of the AHR, represents a new alternative for immunomodulation |
| Q92179686 | Sensing of physiological regulators by innate lymphoid cells |
| Q91706552 | Shared Transcriptional Control of Innate Lymphoid Cell and Dendritic Cell Development |
| Q38693639 | Short Chain Fatty Acids Enhance Aryl Hydrocarbon (Ah) Responsiveness in Mouse Colonocytes and Caco-2 Human Colon Cancer Cells |
| Q35121243 | Shuttling of information between the mucosal and luminal environment drives intestinal homeostasis |
| Q34297607 | Small molecule inhibitors of RORγt: targeting Th17 cells and other applications |
| Q92057552 | Small-molecule-based immunotherapy for immunologically mediated skin conditions |
| Q96226192 | Supplementation of endogenous Ahr ligands reverses insulin resistance and associated inflammation in an insulin-dependent diabetic mouse model |
| Q92445194 | Suppression of Aiolos and Ikaros expression by lenalidomide reduces human ILC3-ILC1/NK cell transdifferentiation |
| Q46050264 | Suppression of CYP1 members of the AHR response by pathogen-associated molecular patterns |
| Q35156077 | T cell contamination in flow cytometry gating approaches for analysis of innate lymphoid cells. |
| Q88156773 | T helper 17 cell/regulatory T-cell imbalance in hidradenitis suppurativa/acne inversa: the link to hair follicle dissection, obesity, smoking and autoimmune comorbidities |
| Q38089355 | T-bet and Gata3 in controlling type 1 and type 2 immunity mediated by innate lymphoid cells |
| Q95831791 | TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer |
| Q35581734 | TNF-α Producing Innate Lymphoid Cells (ILCs) Are Increased in Active Celiac Disease and Contribute to Promote Intestinal Atrophy in Mice |
| Q58078375 | TWARMI pilot trial: The value and optimal criteria of microvolt T-wave alternans in the diagnosis of reversible myocardial ischemia in patients without structural cardiac disease |
| Q38154155 | Taming the beast within: regulation of innate lymphoid cell homeostasis and function. |
| Q50953137 | Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans. |
| Q91285054 | Targeting Aryl hydrocarbon receptor for next-generation immunotherapies: Selective modulators (SAhRMs) versus rapidly metabolized ligands (RMAhRLs) |
| Q94474478 | Targeting cellular fatty acid synthesis limits T helper and innate lymphoid cell function during intestinal inflammation and infection |
| Q46315665 | Targeting the gut microbiota by dietary nutrients: A new avenue for human health |
| Q39488014 | Th17/Treg imbalance in murine cystic fibrosis is linked to indoleamine 2,3-dioxygenase deficiency but corrected by kynurenines. |
| Q48047320 | The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis |
| Q98735457 | The AHR Signaling Attenuates Autoimmune Responses During the Development of Type 1 Diabetes |
| Q96614406 | The AHR1-ARNT1 dimerization pair is a major regulator of the response to natural ligands, but not to TCDD, in the chicken |
| Q46420621 | The Aryl Hydrocarbon Receptor Preferentially Marks and Promotes Gut Regulatory T Cells. |
| Q102376652 | The Aryl Hydrocarbon Receptor in Asthma: Friend or Foe? |
| Q28083139 | The Aryl Hydrocarbon Receptor: A Key Bridging Molecule of External and Internal Chemical Signals |
| Q58612537 | The Aryl Hydrocarbon Receptor: Connecting Immunity to the Microenvironment |
| Q58730243 | The Environmental Sensor AHR Protects from Inflammatory Damage by Maintaining Intestinal Stem Cell Homeostasis and Barrier Integrity |
| Q35641191 | The Group 3 Innate Lymphoid Cell Defect in Aryl Hydrocarbon Receptor Deficient Mice Is Associated with T Cell Hyperactivation during Intestinal Infection |
| Q47148147 | The Immune System Bridges the Gut Microbiota with Systemic Energy Homeostasis: Focus on TLRs, Mucosal Barrier, and SCFAs. |
| Q39077548 | The Immunological Basis of Inflammatory Bowel Disease |
| Q97650579 | The Interaction between Lymphoid Tissue Inducer-Like Cells and T Cells in the Mesenteric Lymph Node Restrains Intestinal Humoral Immunity |
| Q108591583 | The Landscape of AhR Regulators and Coregulators to Fine-Tune AhR Functions |
| Q90229288 | The Microbial Pecking Order: Utilization of Intestinal Microbiota for Poultry Health |
| Q91416779 | The Role of Bacteria and Its Derived Metabolites in Chronic Pain and Depression: Recent Findings and Research Progress |
| Q36947949 | The Role of IL-22 in Viral Infections: Paradigms and Paradoxes |
| Q35595703 | The Role of Microbiota on the Gut Immunology. |
| Q28276657 | The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease |
| Q37662888 | The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin |
| Q88954027 | The Tumor Necrosis Factor Superfamily Member RANKL Suppresses Effector Cytokine Production in Group 3 Innate Lymphoid Cells |
| Q104682576 | The aryl hydrocarbon receptor as a mediator of host-microbiota interplay |
| Q112648488 | The aryl hydrocarbon receptor contributes to tissue adaptation of intestinal eosinophils in mice |
| Q37549732 | The aryl hydrocarbon receptor controls cell-fate decisions in B cells. |
| Q39460723 | The aryl hydrocarbon receptor controls cyclin O to promote epithelial multiciliogenesis |
| Q38346190 | The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology |
| Q38137012 | The aryl hydrocarbon receptor in innate T cell immunity |
| Q87320555 | The aryl hydrocarbon receptor is functionally upregulated early in the course of human T-cell activation |
| Q37346655 | The aryl hydrocarbon receptor is required for the maintenance of liver-resident natural killer cells |
| Q37640488 | The aryl hydrocarbon receptor promotes IL-10 production by NK cells |
| Q41089665 | The aryl hydrocarbon receptor/microRNA-212/132 axis in T cells regulates IL-10 production to maintain intestinal homeostasis |
| Q39040473 | The aryl hydrocarbon receptor: a multifunctional chemical sensor for host defense and homeostatic maintenance |
| Q36980464 | The aryl hydrocarbon receptor: a novel target for immunomodulation in organ transplantation |
| Q83343329 | The aryl hydrocarbon receptor: a sentinel safeguarding the survival of immune cells in the gut |
| Q91341267 | The aryl hydrocarbon receptor: an environmental sensor integrating immune responses in health and disease |
| Q34411397 | The aryl hydrocarbon receptor: multitasking in the immune system |
| Q92627496 | The balance of power: innate lymphoid cells in tissue inflammation and repair |
| Q38319907 | The biology of innate lymphoid cells |
| Q35213604 | The cross talk between microbiota and the immune system: metabolites take center stage |
| Q34448291 | The cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism |
| Q98775451 | The crosstalk between gut bacteria and host immunity in intestinal inflammation |
| Q36711915 | The development of adult innate lymphoid cells |
| Q49645988 | The expanding role of innate lymphoid cells and their T-cell counterparts in gastrointestinal cancers. |
| Q90865084 | The gut microbiome and aquatic toxicology: An emerging concept for environmental health |
| Q28078888 | The gut-brain connection: triggering of brain autoimmune disease by commensal gut bacteria |
| Q91499835 | The interaction of intestinal microbiota and innate lymphoid cells in health and disease throughout life |
| Q34129422 | The interplay between the gut microbiota and the immune system |
| Q35496335 | The interplay between the intestinal microbiota and the immune system |
| Q26740079 | The origin and role of innate lymphoid cells in the lung |
| Q90589872 | The pathogenic role of innate lymphoid cells in autoimmune-related and inflammatory skin diseases |
| Q91803603 | The role of AhR in transcriptional regulation of immune cell development and function |
| Q39215742 | The role of ILC2 in hookworm infection. |
| Q92391321 | The role of inflammation and the gut microbiome in depression and anxiety |
| Q89665184 | The role of innate lymphoid cells in response to microbes at mucosal surfaces |
| Q38115440 | The role of the immune system in governing host-microbe interactions in the intestine |
| Q89282567 | The roles for innate lymphoid cells in the human immune system |
| Q38098490 | The roles of aryl hydrocarbon receptor in immune responses. |
| Q42262891 | The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells. |
| Q24563655 | The transcription factor T-bet is essential for the development of NKp46+ innate lymphocytes via the Notch pathway |
| Q91502664 | The tryptophan derivative 6-formylindolo[3,2-b]carbazole, FICZ, a dynamic mediator of endogenous aryl hydrocarbon receptor signaling, balances cell growth and differentiation |
| Q38478216 | The unusual suspects--innate lymphoid cells as novel therapeutic targets in IBD. |
| Q38174792 | Therapeutic opportunities of the IL-22-IL-22R1 system |
| Q35677809 | They Must Hold Tight: Junction Proteins, Microbiota And Immunity In Intestinal Mucosa |
| Q46754560 | Tissue distribution of aryl hydrocarbon receptor in the intestine: Implication of putative roles in tumor suppression |
| Q38089253 | Tissue-specific effector functions of innate lymphoid cells. |
| Q27026898 | Toward understanding the role of aryl hydrocarbon receptor in the immune system: current progress and future trends |
| Q40572096 | Toxicity of teriflunomide in aryl hydrocarbon receptor deficient mice |
| Q36311181 | Transcription Factor Bcl11b Controls Identity and Function of Mature Type 2 Innate Lymphoid Cells |
| Q41529922 | Transcription factor Dlx3 induces aryl hydrocarbon receptor promoter activity |
| Q38192561 | Transcription factors controlling development and function of innate lymphoid cells |
| Q38231246 | Transcription factors controlling innate lymphoid cell fate decisions |
| Q26785671 | Transcriptional Regulatory Network for the Development of Innate Lymphoid Cells |
| Q35064355 | Transcriptional and epigenetic networks of helper T and innate lymphoid cells. |
| Q38010928 | Transcriptional control of innate lymphocyte fate decisions. |
| Q27005868 | Transcriptional control of innate lymphoid cells |
| Q100465062 | Transcriptional programmes underlying cellular identity and microbial responsiveness in the intestinal epithelium |
| Q38525099 | Transcriptional regulation of innate lymphoid cell fate. |
| Q37712418 | Transcriptional regulators dictate innate lymphoid cell fates |
| Q50554246 | Transcriptional response in rainbow trout (Oncorhynchus mykiss) B cells and thrombocytes following in vivo exposure to benzo[a]pyrene. |
| Q33799561 | Transcriptome analysis reveals similarities between human blood CD3- CD56bright cells and mouse CD127+ innate lymphoid cells. |
| Q45760347 | Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. |
| Q64131158 | Type 3 innate lymphoid cells are altered in colons of C57BL/6 mice with dioxin exposure |
| Q35026463 | Understanding and modulating mammalian-microbial communication for improved human health |
| Q39381331 | Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System |
| Q36180686 | Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation |
| Q39763196 | Vitamin A Controls the Presence of RORγ+ Innate Lymphoid Cells and Lymphoid Tissue in the Small Intestine |
| Q40241403 | Vitamin D downregulates the IL-23 receptor pathway in human mucosal group 3 innate lymphoid cells |
| Q91610516 | Vitamin D/Vitamin D Receptor Signaling Is Required for Normal Development and Function of Group 3 Innate Lymphoid Cells in the Gut |
| Q33786520 | WASH maintains NKp46+ ILC3 cells by promoting AHR expression |
| Q37486151 | Xenobiotic Receptor-Mediated Regulation of Intestinal Barrier Function and Innate Immunity |
| Q57279978 | Xenobiotic and endobiotic handling by the mucosal immune system |
| Q90388552 | c-Maf regulates the plasticity of group 3 innate lymphoid cells by restraining the type 1 program |
| Q104478151 | β-Naphthoflavone Activation of the Ah Receptor Alleviates Irradiation-Induced Intestinal Injury in Mice |
Search more.